Tag Archives: LP.8.1 variant

EMA Recommends Approval of Pfizer-BioNTech’s LP.8.1 COVID-19 Vaccine for Broad Use in EU

(IN BRIEF) Pfizer and BioNTech have received a positive recommendation from the EMA’s CHMP for their LP.8.1-adapted monovalent COVID-19 vaccine, COMIRNATY® LP.8.1, for individuals aged six months and older. This updated vaccine offers improved immune protection against prevalent SARS-CoV-2 subvariants, … Read the full press release